Clinical Trials Browser

OTHER × Malignant Ascites × pembrolizumab × Clear all

NCT05745233 2023-08-24

Intraperitoneal Immune Checkpoint Inhibitor for Malignant Ascites

Phase NA Enrolling by invitation

Malignant Ascites